Tech Company Inital Public Offerings
Ignyta IPO
On 3/14/2014, Ignyta completed its IPO
Transaction Overview
Company Name
Announced On
3/14/2014
Transaction Type
IPO
Amount
$47,580,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
11095 Flintkote Avenue d
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Ignyta is developing leading cancer treatments by developing selective tyrosine kinase inhibitors of the TrkA, TrkB, TrkC, ROS1 and ALK proteins.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonathan Lim
Chief Financial Officer
Jacob Chacko
Chief Medical Officer
Adrian Senderowicz
Chief Operating Officer
Zachary Hornby
Chief Scientific Officer
Robert Wild
VP - General Counsel
Matt Onaitis
Browse more venture capital transactions:
Prev: 3/14/2014: Xapo venture capital transaction
Next: 3/14/2014: Klutch venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs